UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
11.55
+0.10 (0.87%)
Nov 21, 2024, 4:00 PM EST - Market closed
UroGen Pharma Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$44.50
Upside
+285.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +116.45% | Nov 6, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +116.45% | Oct 29, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +116.45% | Oct 21, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +116.45% | Oct 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $40 | Buy | Reiterates | $40 | +246.32% | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $64 | Strong Buy | Maintains | $60 → $64 | +454.11% | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +419.48% | Oct 15, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +116.45% | Oct 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +419.48% | Oct 3, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +246.32% | Aug 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +419.48% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +419.48% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +419.48% | Jul 1, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $48 → $54 | Strong Buy | Maintains | $48 → $54 | +363.20% | Jun 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +246.32% | Jun 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $54 → $60 | Strong Buy | Maintains | $54 → $60 | +419.48% | Jun 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.